Form 8-K - Current report:
SEC Accession No. 0001213900-25-071392
Filing Date
2025-08-04
Accepted
2025-08-04 16:45:47
Documents
12
Period of Report
2025-08-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0251413-8k425_helix2.htm   iXBRL 8-K 65314
  Complete submission text file 0001213900-25-071392.txt   241544

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hlxb-20250804.xsd EX-101.SCH 3053
3 XBRL LABEL FILE hlxb-20250804_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE hlxb-20250804_pre.xml EX-101.PRE 22384
14 EXTRACTED XBRL INSTANCE DOCUMENT ea0251413-8k425_helix2_htm.xml XML 3815
Mailing Address C/O CORMORANT ASSET MANAGEMENT, LP 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address C/O CORMORANT ASSET MANAGEMENT, LP 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116 857 702 0377
Helix Acquisition Corp. II (Filer) CIK: 0001869105 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41955 | Film No.: 251181061
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)